A short, evidence-grounded conversation about Apigenin and its place in longevity science.
Speaker 1
...So, apigenin, it’s a flavone, a type of plant pigment. You find it in chamomile, parsley, celery. But why are longevity researchers so interested in it?
Speaker 2
It boils down to its role as a CD38 inhibitor. CD38 is an enzyme, and its primary job is to break down NAD⁺, a coenzyme critical for countless cellular processes, including energy production and DNA repair.
Speaker 1
Right, and NAD⁺ levels naturally decline as we age. So, if CD38 is breaking it down, then inhibiting CD38 could help preserve NAD⁺.
Speaker 2
Exactly. By inhibiting CD38, apigenin essentially slows that NAD⁺ breakdown, potentially helping maintain higher NAD⁺ levels. This is why it’s often discussed within the context of the NAD⁺/Sirtuin axis, a key pathway in aging research.
Speaker 1
So, the idea is that by preserving NAD⁺, you're supporting these vital cellular functions that tend to falter with age. But is this effect proven in humans?
Speaker 2
That's the big question. While in vitro and animal studies, like one in Nature Communications in 2020, show promising results regarding CD38 inhibition and NAD⁺ preservation, we still lack robust human clinical trials specifically demonstrating apigenin’s impact on human NAD⁺ levels and subsequent longevity outcomes.
Speaker 1
So, for now, it's a fascinating molecule because of its mechanism, but we’re waiting on more human data to confirm its broader longevity benefits.
Speaker 2
Precisely. It highlights an important area of research, but the direct, long-term impact on human aging is still unproven.
Educational research discussion only — not medical advice. Statements have not been
evaluated by the FDA. Nothing here is intended to diagnose, treat, cure or prevent any disease.
Talk to a qualified clinician before changing any treatment.